During a system upgrade from Friday, Dec. 5, through Sunday, Dec. 7, the AAFP website, on-demand courses and CME purchases will be unavailable.
Advances in Brain Health: Blood Biomarkers (BBMs) in Alzheimer’s Dementia (AD)
Free On Demand CME
Alzheimer’s Dementia (AD) remains a challenging clinical diagnosis, particularly in the early stages of cognitive decline. With a shortage of dementia care specialists and direct care workers, family physicians play a critical role in bridging the care gap.
This enduring self-study activity is designed to enhance your knowledge and clinical competence in caring for patients with cognitive decline and Alzheimer’s disease specifically.
The approximately 4-hour CME course will address key educational gaps identified through research and the AAFP’s 2024 Voices of Alzheimer’s survey. Topics will include:
- Addressing barriers to implementing annual cognitive screening
- BBM test selection criteria and test characteristics
- Diagnosis and care pathways, including next steps following a positive cognitive impairment result
- Basic science and technology behind BBMs
You will be able to access pertinent content after the activity concludes. Continued access to the included visual aids will help you familiarize yourself with images of various conditions.
Earn 3.75 CME credits.
The Role of Family Physicians in Early Detection of Alzheimer’s Disease
Ariel Cole, MD, FAAFP
The Science Behind Blood Biomarkers (BBMs) for Alzheimer Disease: What Family Physicians Need to Know
Diana P. Summanwar, MD; Deanna R. Willis, MD, FAAFP
Next Steps After a Positive Cognitive Impairment Screening: Diagnosis and Care Pathways
Diana P. Summanwar, MD; Deanna R. Willis, MD, FAAFP
Educating Patients and Care Partners on Cognitive Health: Strategies and Best Practices
Ecler Jaqua, MD, MBA, FAAFP, AGSF, FACLM
From Theory to Practice: Applying Blood Biomarkers to Improve Patient Outcomes
Ariel Cole, MD, FAAFP; Ecler Jaqua, MD, MBA, FAAFP, AGSF, FACLM; Diana P. Summanwar, MD; Deanna R. Willis, MD, FAAFP
Upon completion of this CME activity, you should be able to:
- Recognize the role of family physicians in the early detection and treatment of Alzheimer’s Disease (AD).
- Discuss the science behind blood biomarkers (BBMs) and their importance in diagnosing AD.
- Identify and evaluate different types of BBMs for AD, including their key characteristics and selection criteria.
- Develop effective diagnosis and care pathways for patients with positive cognitive impairment results.
- Enhance communication strategies to educate patients about cognitive health and promote best practices for preventing cognitive decline.
- Translate knowledge of BBMs to improve patient outcomes through practical applications and consideration of their use in clinical practice.
- High-speed broadband connection required for online access.
- Latest version of Firefox, Safari, or Chrome on Windows or Macintosh computers or tablets.
- Latest version of Adobe Reader.
This CME activity is supported by an educational grant to the AAFP from USAgainstAlzheimer's.
The AAFP has reviewed Advances in Brain Health: Blood Biomarkers (BBM) in Alzheimer's Dementia (AD) and deemed it acceptable for up to 3.75 Enduring Materials, Self-Study AAFP Prescribed credit(s). Term of Approval is from 09/16/2025 to 09/16/2027. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AAFP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Family Physicians designates this Enduring Materials for a maximum of 3.75 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME activities approved for AAFP credit are recognized by the AOA as equivalent to AOA Category 2 credit.
Following this CME activity, participants will have the opportunity to earn an additional two Prescribed credits for participation in each Translation to Practice® exercise. Information on Translation to Practice® will be shared within the activity.